Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Megumi Go"'
Autor:
Clémence Kiho Bourgeois Yoshioka, Nana Takenaka-Ninagawa, Megumi Goto, Mayuho Miki, Daiki Watanabe, Masamichi Yamamoto, Tomoki Aoyama, Hidetoshi Sakurai
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-24 (2024)
Abstract Background Duchenne muscular dystrophy (DMD) is an incurable neuromuscular disease leading to progressive skeletal muscle weakness and fatigue. Cell transplantation in murine models has shown promise in supplementing the lack of the dystroph
Externí odkaz:
https://doaj.org/article/c8652efa539f471d8520c99fa9124f5a
Publikováno v:
Frontiers in Physiology, Vol 14 (2023)
Duchenne muscular dystrophy (DMD) is an X-linked fatal muscular disease, affecting one in 3,500 live male births worldwide. Currently, there is no cure for this disease, except for steroid-based treatment to attenuate disease progression. Cell transp
Externí odkaz:
https://doaj.org/article/19836df5eb434a1a9f257bb3af7bb5a7
Autor:
Kousaku Sato, Hiroyuki Katoh, Toshiji Motohara, Toshiyuki Takahashi, Megumi Go, Tetsuyuki Okubo, Toshiya Nishibe, Mitsuru Doke, Shunichi Okushiba
Publikováno v:
The journal of the Japanese Practical Surgeon Society. 56:1373-1376
Small cell carcinoma of the esophagus has a poor prognosis. It has been reported that the mean survival period is 5.3 months. Recently we experienced two resected cases of small cell carcinoma of the esophagus survived more than two years after surge
Autor:
Nana Takenaka-Ninagawa, Jinsol Kim, Mingming Zhao, Masae Sato, Tatsuya Jonouchi, Megumi Goto, Clémence Kiho Bourgeois Yoshioka, Rukia Ikeda, Aya Harada, Takahiko Sato, Makoto Ikeya, Akiyoshi Uezumi, Masashi Nakatani, Satoru Noguchi, Hidetoshi Sakurai
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-18 (2021)
Abstract Background Mesenchymal stromal cells (MSCs) function as supportive cells on skeletal muscle homeostasis through several secretory factors including type 6 collagen (COL6). Several mutations of COL6A1, 2, and 3 genes cause Ullrich congenital
Externí odkaz:
https://doaj.org/article/8208615de2514f5b8decc05ee6e873df
Autor:
Megumi Go, Takehiko Oura, Noboru Sakai, Tatsuzo Tanabe, Tetsunori Yoshida, Hiroyuki Kato, Satoshi Fukuda, Hidehiko Minagawa, Shunichi Okushiba, Eiji Shimozawa, Masao Inuyama
Publikováno v:
The journal of the Japanese Practical Surgeon Society. 54:861-864
Autor:
Aya Harada, Megumi Goto, Atsuya Kato, Nana Takenaka-Ninagawa, Akito Tanaka, Satoru Noguchi, Makoto Ikeya, Hidetoshi Sakurai
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Collagen VI is distributed in the interstitium and is secreted mainly by mesenchymal stromal cells (MSCs) in skeletal muscle. Mutations in COL6A1-3 genes cause a spectrum of COL6-related myopathies. In this study, we performed a systemic transplantat
Externí odkaz:
https://doaj.org/article/e107aff9d8cc4e0b97962fd95c16cce6
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 6, Iss 1, Pp 133-141 (2016)
Background: Brain perfusion may differ between patients with corticobasal syndrome (CBS) with and without aphasia. Methods: Twenty-six (9 males and 17 females; mean age 76 ± 5.3 years) patients with CBS were enrolled in the study. Brain MRI and sing
Externí odkaz:
https://doaj.org/article/01003b9a3bd84fb494a3f9e1457a0dad
Autor:
Masahito Katahira, Hidetada Ogata, Takahiro Ito, Tsutomu Miwata, Megumi Goto, Shizuka Nakamura, Hiromi Takashima
Publikováno v:
Journal of Diabetes Research, Vol 2018 (2018)
The presence of antiglutamic acid decarboxylase antibody (GADA) is required for the diagnosis of slowly progressive type 1 diabetes (SPT1D). We examined the factors influencing GADA determination by radioimmunoassay (GADA-RIA) and by enzyme-linked im
Externí odkaz:
https://doaj.org/article/bbb29aef95b342359d10dc18e9a25d6c
Autor:
Oliver J Sabot, Alex Mwita, Justin M Cohen, Yahya Ipuge, Megumi Gordon, David Bishop, Moses Odhiambo, Lorrayne Ward, Catherine Goodman
Publikováno v:
PLoS ONE, Vol 4, Iss 9, p e6857 (2009)
WHO estimates that only 3% of fever patients use recommended artemisinin-based combination therapies (ACTs), partly reflecting their high prices in the retail sector from where many patients seek treatment. To overcome this challenge, a global ACT su
Externí odkaz:
https://doaj.org/article/d7ae522e865d4236a6d8f9fbc03865e2